Professor, Director, Craniofacial Anomalies Research Center
University of Iowa
Iowa city, Iowa
Brad A Amendt completed his PhD at the University of Iowa in 1994. He was an Assistant Professor at the University of Tulsa, Tulsa, OK, Professor and Associate Dean at the University of Texas A&M Health Science Center, Institute for Biosciences and Technology, Houston, TX. He is currently the Director of the Craniofacial Anomalies Research Center at the University of Iowa, Iowa City, IA. He has published more than 70 manuscripts, several books and book chapters and is the Founder and CSO of NaturemiRI, LLC. His team is developing clinical trials to test new biotechnology. His research group focus on develop the Plasmid-Based microRNA Inhibitor System (PMIS) to determine the roles of miRs during craniofacial development. The PMIS effectively knocks down the activity of miR clusters to allow for the analyses of multiple miRs on separate chromosomes. This is the first demonstration of an in vitro system to knock down miR clusters. Dr. Amendt received craniofacial biology research award from IADR and currently is president of stem cell biology scientific group of the IADR
Disclosure information not submitted.
Wednesday, May 3, 2023
1:00 PM – 1:15 PM CT